Clinical reference Biomarker Directory
Back to directory

TPSAB1

Established

TPSAB1/tryptase is central to diagnosing mastocytosis and anaphylaxis, complicated by a distinct genetic trait (hereditary alpha-tryptasemia).

Also known as Tryptase alpha-tryptase
In plain language

Tryptase is released by immune cells during allergic reactions, and testing it helps diagnose both anaphylaxis and a mast cell disease called mastocytosis. A separate, more recently discovered genetic trait can also raise this same baseline level and cause its own allergy risk — telling the two apart now requires a specific genetic test, not just the tryptase level itself.

Biomarker & context

TPSAB1 encodes alpha-tryptase, one form of the enzyme tryptase released by mast cells; serum tryptase testing is central to diagnosing mastocytosis and confirming anaphylaxis.

What it indicates

Elevated baseline serum tryptase supports systemic mastocytosis diagnosis, while a significant rise from an individual's own baseline shortly after a reaction supports anaphylaxis; beyond these classic uses, this gene is the site of a genuinely important, relatively recently described (2016) genetic condition.

Diagnosis & clinical testing

Hereditary alpha-tryptasemia, caused by extra copies of the TPSAB1 gene, elevates baseline tryptase and increases risk of severe allergic reactions independent of mastocytosis — a real diagnostic complication since it can be mistaken for or coexist with mastocytosis, requiring genetic copy-number testing (rather than just a tryptase blood level) to properly distinguish the two conditions.

Guiding treatment

In patients with elevated baseline tryptase, current diagnostic workup increasingly includes screening for both the KIT D816V mutation (mastocytosis) and TPSAB1 copy number (hereditary alpha-tryptasemia), since distinguishing them can avoid an unnecessary bone marrow biopsy in patients whose elevated tryptase is explained by the genetic trait alone.

Clinical significance

Distinguishing hereditary alpha-tryptasemia from true mastocytosis requires genetic copy-number testing, not tryptase level alone.

References
  1. Swiss Medical Weekly. (2025). Hereditary alpha-tryptasemia — a potential cause of severe anaphylactic reactions and a modifier of mast cell diseases.
  2. Current Allergy and Asthma Reports. (2026). Hereditary Alpha-Tryptasemia and Mastocytosis: What We Know and What We Need To Learn.